IP Library › Granted Patent US 7,122,354
Granted Patent B2
US 7,122,354 · App. 10/318,905 · Granted Oct 17, 2006

Nucleic acid encoding a chimeric polypeptide

Assignee: Transkaryotic Therapies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,122,354
App. No.
10/318,905
Granted
Oct 17, 2006
Kind
B2
Abstract

DNA molecules comprising a sequence encoding the signal peptide of hGH linked to a heterologous protein and related cells, methods and fusion proteins.

Claims (9)

1. A cultured cell comprising a nucleic acid sequence that encodes the signal peptide of human growth hormone (hGH) linked to a nucleic acid encoding a polypeptide selected from the group consisting of α-1 antitrypsin, antithrombin III, apolipoprotein E, apolipoprotein A-1, Factor V, Factor VII, Factor VIII, Factor IX, Factor X, Factor XIII, bone growth factor-2, bone growth factor-7, calcitonin, a catalytic antibody, DNAse, erythropoietin, FSH-β, DNAase, globin, glucagon, granulocyte macrophage colony stimulating factor, an immune response modifier, an immunoglobulin, insulin, insulinotropin, an insulin-like growth factor, interferon-β, an interferon-β nerve growth factor, interleukin-1, interleukin-3, interleukin-4, interleukin-6, interleukin-11, interleukin-12, an interleukin-2 receptor, an IL-1 receptor antagonist, a low density lipoprotein receptor, macrophage-colony stimulating factor, parathyroid hormone, protein kinase C, soluble CD4, superoxide dismutase, tissue plasminogen activator, transforming growth factor β, tumor necrosis factor, thyroid stimulating hormone β, tyrosine hydroxylase, and urokinase, wherein the nucleic acid sequence is stably integrated into the cell and provides increased expression and secretion of the polypeptide from the cell as compared to expression and secretion of the polypeptide with a signal peptide that is naturally associated with the polypeptide.

2. The cell of claim 1 , wherein the nucleic acid sequence that encodes the signal peptide of hGH includes an intron.

3. The cell of claim 2 , wherein the intron comprises the first hGH intron.

4. The cell of claim 1 , wherein the cell is a human cell.

5. The cell of claim 1 , wherein the cell is a fibroblast.

6. The cell of claim 1 , wherein the cell is an epithelial cell, an endothelial cell, a lymphocyte, a bone marrow cell, a glial cell, a hepatocyte, a keratinocyte, a muscle cell, a neural cell, a Bowes melanoma cell, a Daudi cell, a HeLa cell, an HL-60 cell, an HT1080 cell, a Jurkat cell, a KB carcinoma cell, a K-562 leukemia cell, an MCF-7 breast cancer cell, a MOLT-4 cell, a Namalwa cell, a Raji cell, an RPMI 8226 cell, a U-937 cell, a WI-38VA13 subline 2R4 cell, a 2780AD ovarian carcinoma cell, a WI-38 cell, or an MRC-5 cell.

7. A method of obtaining a polypeptide, the method comprising

(a) culturing the cell of claim 1 , and

(b) isolating the polypeptide from the cell or from the culture medium of the cell.

Assignments (2)
CHANGE OF NAME Recorded Aug 31, 2006
From: TRANSKARYOTIC THERAPIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 018224/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2006
From: SELDEN, RICHARD F.; BOROWSKI, MARIANNE; GILLISPIE, FRANCES P.; KINOSHITA, CAROL M.; TRECO, DOUGLAS A.; WILIAMS, MELANIE D.
To: TRANSKARYOTIC THERAPIES, INC.
Reel/Frame 017874/0953 →
Continuity (4)
Continuation 0949175900 · Jan 27, 2000
Continuation 0892888100 · Sep 12, 1997
Provisional Application 6002604100 · Sep 13, 1996
Related Publication 20030152560A1 · Aug 14, 2003